Detalhe da pesquisa
1.
Children develop robust and sustained cross-reactive spike-specific immune responses to SARS-CoV-2 infection.
Nat Immunol
; 23(1): 40-49, 2022 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-34937928
2.
Severe Acute Respiratory Syndrome Coronavirus 2 Anti-Spike Antibody Levels Following Second Dose of ChAdOx1 nCov-19 or BNT162b2 Vaccine in Residents of Long-term Care Facilities in England (VIVALDI).
J Infect Dis
; 226(11): 1877-1881, 2022 11 28.
Artigo
em Inglês
| MEDLINE | ID: mdl-35429382
3.
Strong peak immunogenicity but rapid antibody waning following third vaccine dose in older residents of care homes.
Nat Aging
; 3(1): 93-104, 2023 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-37118525
4.
Immunological imprinting of humoral immunity to SARS-CoV-2 in children.
Nat Commun
; 14(1): 3845, 2023 06 29.
Artigo
em Inglês
| MEDLINE | ID: mdl-37386081
5.
Prevalence and duration of detectable SARS-CoV-2 nucleocapsid antibodies in staff and residents of long-term care facilities over the first year of the pandemic (VIVALDI study): prospective cohort study in England.
Lancet Healthy Longev
; 3(1): e13-e21, 2022 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-34935001
6.
Antibody and cellular immune responses following dual COVID-19 vaccination within infection-naive residents of long-term care facilities: an observational cohort study.
Lancet Healthy Longev
; 3(7): e461-e469, 2022 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-35813280
7.
mRNA or ChAd0x1 COVID-19 Vaccination of Adolescents Induces Robust Antibody and Cellular Responses With Continued Recognition of Omicron Following mRNA-1273.
Front Immunol
; 13: 882515, 2022.
Artigo
em Inglês
| MEDLINE | ID: mdl-35720281
8.
Robust SARS-CoV-2-specific and heterologous immune responses in vaccine-naïve residents of long-term care facilities who survive natural infection.
Nat Aging
; 2(6): 536-547, 2022 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-37118449
9.
Profile of humoral and cellular immune responses to single doses of BNT162b2 or ChAdOx1 nCoV-19 vaccines in residents and staff within residential care homes (VIVALDI): an observational study.
Lancet Healthy Longev
; 2(9): e544-e553, 2021 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-34430954
10.
Robust generation of neutralising antibodies against Omicron variants following bivalent mRNA booster vaccine in elderly people aged >80 years.
J Infect
; 88(1): 48-50, 2024 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-37660756
11.
Enhancement of Omicron-specific immune responses following bivalent COVID-19 booster vaccination in patients with chronic lymphocytic leukaemia.
Blood Cancer J
; 14(1): 22, 2024 01 25.
Artigo
em Inglês
| MEDLINE | ID: mdl-38272915
12.
COVID-19 vaccines elicit robust cellular immunity and clinical protection in chronic lymphocytic leukemia.
Cancer Cell
; 40(6): 584-586, 2022 06 13.
Artigo
em Inglês
| MEDLINE | ID: mdl-35588735